Profile for Progression of a Hyaluronic Acid-Based Nanocarrier Integrating Doxorubicin as well as Cisplatin being a pH-Sensitive and CD44-Targeted Anti-Breast Cancer malignancy Drug Delivery Program. (furplate27)